Pluvia Biotech
PrivateLast Round
Seed
May 19, 2026
Total Funding Raised
$1.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pluvia Biotech is a biotechnology company that develops oral pharmacological chaperones for the treatment of rare genetic disorders caused by protein misfolding, such as phenylketonuria (PKU).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pluvia Biotech Comparables
Compare Pluvia Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atlas Molecular Pharma | 82% | |
| SOM Biotech | 81% | |
| Otsuka Holdings | 75% | |
Pluvia Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 19, 2026 | ||||
| Grant | Nov 25, 2025 | ||||
| Seed | Mar 1, 2017 |
Pluvia Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investinor | Seed |
| Tidligfasekapital Vestland | Seed |
| Trond Mohn Research Foundation | Seed |
| Sarsia | Seed |
| MABA | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Secured Seed funding from Investinor, Sarsia, and others.
- Oct 27, 2024
Monthly visitors grew 40% MoM, from 860 to 1.2K.
Pluvia Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pluvia Biotech's valuation, stock price, and market status.